Suchergebnisse - "Mu, Guangyan"

PubPharm (85)

51

Different Coagulation Indicators in Predicting Clinical Outcomes for Patients With Direct Oral Anticoagulants : A Systematic Review and Meta-analysis

enthalten in: Clinical therapeutics | 2020

von Liu, Z. | Zhang, H. | Xie, Q. | +7

52

Anti-FXa-IIa activity test in Asian and its potential role for drug adherence evaluation in patients with direct oral anticoagulants : a nationwide multi-center synchronization study

enthalten in: Cardiovascular diagnosis and therapy | 2020

von Liu, Z. | Xie, Q. | Xiang, Q. | +14

53

Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil : a case report

enthalten in: BMC pharmacology & toxicology | 2020

von Xiang, Q. | Liu, Z. | Yu, Y. | +6

54

Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report

enthalten in: BMC pharmacology & toxicology | 2020

von Xiang, Q. | Liu, Z. | Yu, Y. | +6

55

Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report

enthalten in: BMC pharmacology & toxicology | 2020

von Xiang, Q. | Liu, Z. | Yu, Y. | +6

56

PNPT1 and PCGF3 variants associated with angiotensin-converting enzyme inhibitor-induced cough : a nested case-control genome-wide study

enthalten in: Pharmacogenomics | 2020

von Mu, G. | Xiang, Q. | Zhang, Z. | +13

57

Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients at High Cardiovascular Risk : An Updated Systematic Review and Meta-Analysis of 32 Randomized Controlled Trials

enthalten in: Advances in therapy | 2020

von Mu, G. | Xiang, Q. | Zhou, S. | +9

58

Accuracy of HAS-BLED and other bleeding risk assessment tools in predicting major bleeding events in atrial fibrillation : A network meta-analysis

enthalten in: Journal of thrombosis and haemostasis : JTH | 2020

von Chang, G. | Xie, Q. | Ma, L. | +4

59

Associations Between Polymorphisms of Endothelial Nitric Oxide Synthase, Matrix Metalloproteinase 3, Angiotensinogen, and Angiotensin II Type 1 Receptor and Risk of Restenosis After Percutaneous Coronary Intervention : A Meta-analysis

enthalten in: Clinical therapeutics | 2020

von Zhou, S. | Mu, G. | Wei, S. | +4

60

Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients at High Cardiovascular Risk: An Updated Systematic Review and Meta-Analysis of 32 Randomized Controlled Trials

enthalten in: Advances in therapy | 2020

von Mu, G. | Xiang, Q. | Zhou, S. | +9